Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Żeromskiego 113, 90-549 Lodz, Poland.
Nutrients. 2022 May 4;14(9):1921. doi: 10.3390/nu14091921.
The role of gut microbiota and its association with the central nervous system via the microbiome-brain-gut axis has been widely discussed in the literature. The aim of this review is to investigate the impact of gut microbiota on the development of depression and underlying molecular mechanisms. There are two possible pathways in which this interaction might occur. The first one suggests that depressive disorder could lead to dysbiosis and one of the causes may be the influence on the hypothalamic-pituitary-adrenal (HPA) axis. The second one considers if changes in the composition of gut microbiota might cause depressive disorder. The mechanisms that could be responsible for this interaction include the secretion of neurotransmitters, gut peptides and the activation of the immune system. However, current knowledge on this topic does not allow for us to state an unambiguous conclusion, and future studies that take into consideration more precise stress-measurement methods are needed to further explore direct mechanisms of the interaction between gut microbiota and mental health.
肠道微生物群及其通过微生物群-肠-脑轴与中枢神经系统的关联在文献中被广泛讨论。本综述的目的是探讨肠道微生物群对抑郁症发展的影响及其潜在的分子机制。这种相互作用可能有两种途径。第一种途径表明,抑郁障碍可能导致肠道菌群失调,其中一个原因可能是对下丘脑-垂体-肾上腺 (HPA) 轴的影响。第二种途径则考虑肠道微生物群的组成变化是否会导致抑郁障碍。可能导致这种相互作用的机制包括神经递质、肠道肽的分泌和免疫系统的激活。然而,目前对这一主题的了解还不允许我们得出明确的结论,需要进行更多考虑更精确的应激测量方法的未来研究,以进一步探索肠道微生物群与心理健康之间相互作用的直接机制。